{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:27:40Z","timestamp":1793964460964,"version":"4.8.0"},"reference-count":230,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Chem"],"DOI":"10.1038\/s41570-026-00867-y","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:28:09Z","timestamp":1787225289000},"page":"761-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting soluble misfolded oligomers in anti-amyloid research"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6894-5463","authenticated-orcid":false,"given":"Pernille","family":"Vosbein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6720-9429","authenticated-orcid":false,"given":"Hanbin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9521-8285","authenticated-orcid":false,"given":"Chenguang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"867_CR1","doi-asserted-by":"publisher","first-page":"12448","DOI":"10.3390\/ijms252212448","volume":"25","author":"M Sidoryk-W\u0119grzynowicz","year":"2024","unstructured":"Sidoryk-W\u0119grzynowicz, M., Adamiak, K. & Stru\u017cy\u0144ska, L. Targeting protein misfolding and aggregation as a therapeutic perspective in neurodegenerative disorders. Int. J. Mol. Sci. 25, 12448 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR2","doi-asserted-by":"publisher","first-page":"102017","DOI":"10.1016\/j.arr.2023.102017","volume":"90","author":"S Basha","year":"2023","unstructured":"Basha, S. et al. A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies. Ageing. Res. Rev. 90, 102017 (2023).","journal-title":"Ageing. Res. Rev."},{"key":"867_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-023-00651-2","volume":"19","author":"DJ Rinauro","year":"2024","unstructured":"Rinauro, D. J., Chiti, F., Vendruscolo, M. & Limbocker, R. Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases. Mol. Neurodegener. 19, 20 (2024).","journal-title":"Mol. Neurodegener."},{"key":"867_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s42466-019-0039-8","volume":"1","author":"AP Marsh","year":"2019","unstructured":"Marsh, A. P. Molecular mechanisms of proteinopathies across neurodegenerative disease: a review. Neurol. Res. Pract. 1, 35 (2019).","journal-title":"Neurol. Res. Pract."},{"key":"867_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","volume":"19","author":"MG Iadanza","year":"2018","unstructured":"Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A. & Radford, S. E. A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell Biol. 19, 755\u2013773 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"867_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47151-2","volume":"9","author":"L Zhai","year":"2019","unstructured":"Zhai, L., Otani, Y. & Ohwada, T. Uncovering the networks of topological neighborhoods in \u03b2-strand and amyloid \u03b2-sheet structures. Sci. Rep. 9, 10737 (2019).","journal-title":"Sci. Rep."},{"key":"867_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41580-023-00647-2","volume":"24","author":"N Louros","year":"2023","unstructured":"Louros, N., Schymkowitz, J. & Rousseau, F. Mechanisms and pathology of protein misfolding and aggregation. Nat. Rev. Mol. Cell. Biol. 24, 912\u2013933 (2023).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"867_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A. & Higgins, G. A. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 256, 184\u2013185 (1992). This seminal paper proposes the amyloid cascade hypothesis, laying the foundation for linking A\u03b2 accumulation to Alzheimer\u2019s disease pathology.","journal-title":"Science."},{"key":"867_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"867_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/brainsci15101101","volume":"15","author":"B Zhang","year":"2025","unstructured":"Zhang, B., Li, Y., Li, H., Shen, X. & Zhu, Z. Therapeutic advances in targeting the amyloid-\u03b2 pathway for Alzheimer\u2019s disease. Brain Sci. 15, 1101 (2025).","journal-title":"Brain Sci."},{"key":"867_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat. Rev. Mol. Cell Biol. 8, 101\u2013112 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"867_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","volume":"14","author":"B-H Kim","year":"2025","unstructured":"Kim, B.-H. et al. Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives. Transl. Neurodegener. 14, 6 (2025).","journal-title":"Transl. Neurodegener."},{"key":"867_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2515673122","volume":"122","author":"RS Palani","year":"2025","unstructured":"Palani, R. S. et al. Aducanumab binding to A\u03b21\u201342 fibrils alters dynamics of the N-terminal tail while preserving the fibril core. Proc. Natl Acad. Sci. USA 122, e2515673122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR14","unstructured":"Eisai Inc. A study to confirm safety and efficacy of lecanemab in participants with early Alzheimer\u2019s disease (Clarity AD). ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03887455 (2022)."},{"key":"867_CR15","unstructured":"Biogen. 221AD301 phase 3 study of aducanumab (BIIB037) in early Alzheimer\u2019s disease (ENGAGE). ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02477800 (2021)."},{"key":"867_CR16","unstructured":"Biogen. 221AD302 phase 3 study of aducanumab (BIIB037) in early Alzheimer\u2019s disease (EMERGE). ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02484547 (2021)."},{"key":"867_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims, J. R. et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330, 512\u2013527 (2023).","journal-title":"JAMA"},{"key":"867_CR18","doi-asserted-by":"publisher","first-page":"143725","DOI":"10.1016\/j.ijbiomac.2025.143725","volume":"311","author":"S Basha","year":"2025","unstructured":"Basha, S., Mukunda, D. C., Pai, A. R. & Mahato, K. K. Assessing amyloid fibrils and amorphous aggregates: a review. Int. J. Biol. Macromol. 311, 143725 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"867_CR19","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/jcb.30141","volume":"122","author":"P Madhu","year":"2021","unstructured":"Madhu, P. & Mukhopadhyay, S. Distinct types of amyloid-\u03b2 oligomers displaying diverse neurotoxicity mechanisms in Alzheimer\u2019s disease. J. Cell. Biochem. 122, 1594\u20131608 (2021).","journal-title":"J. Cell. Biochem."},{"key":"867_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70184","volume":"11","author":"JM Kaplan","year":"2025","unstructured":"Kaplan, J. M. et al. Relationship between efficacy and preferential targeting of soluble A\u03b2 aggregates. Alzheimer\u2019s Dement. 11, e70184 (2025).","journal-title":"Alzheimer\u2019s Dement."},{"key":"867_CR21","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1007\/s10072-025-08456-5","volume":"46","author":"A Gupta","year":"2025","unstructured":"Gupta, A., Pahal, S., Kumar, V. & Chaudhary, A. Role of monoclonal antibodies in Alzheimer\u2019s disease: successes, failures, and future directions. Neurol. Sci. 46, 5607\u20135619 (2025).","journal-title":"Neurol. Sci."},{"key":"867_CR22","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","volume":"64","author":"EN Cline","year":"2018","unstructured":"Cline, E. N., Bicca, M. A., Viola, K. L. & Klein, W. L. The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade. J. Alzheim. Dis. 64, S567\u2013S610 (2018). This review collects evidence for the A\u03b2O hypothesis, emphasizing soluble oligomers as key toxic species in Alzheimer\u2019s disease.","journal-title":"J. Alzheim. Dis."},{"key":"867_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal. Transduct. Target. Ther. 9, 211 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"867_CR24","doi-asserted-by":"publisher","first-page":"124231","DOI":"10.1016\/j.ijbiomac.2023.124231","volume":"239","author":"S Ghosh","year":"2023","unstructured":"Ghosh, S., Ali, R. & Verma, S. A\u03b2-oligomers: a potential therapeutic target for Alzheimer\u2019s disease. Int. J. Biol. Macromol. 239, 124231 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"867_CR25","unstructured":"Alzheimer\u2019s Disease International \u2013 Dementia statistics. Alzheimer\u2019s Disease International https:\/\/www.alzint.org\/about\/dementia-facts-figures\/dementia-statistics\/ (2025)."},{"key":"867_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Chen, H., Li, R., Sterling, K. & Song, W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal. Transduct. Target. Ther. 8, 248 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"867_CR27","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen, G. F. et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 38, 1205\u20131235 (2017).","journal-title":"Acta Pharmacol. Sin."},{"key":"867_CR28","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1039\/C4SC02517B","volume":"6","author":"R Cukalevski","year":"2015","unstructured":"Cukalevski, R. et al. The A\u03b240 and A\u03b242 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation. Chem. Sci. 6, 4215\u20134233 (2015).","journal-title":"Chem. Sci."},{"key":"867_CR29","doi-asserted-by":"publisher","first-page":"24426","DOI":"10.1021\/jacs.4c06372","volume":"146","author":"F Meng","year":"2024","unstructured":"Meng, F., Kim, J. Y., Louis, J. M. & Chung, H. S. Single-molecule characterization of heterogeneous oligomer formation during co-aggregation of 40- and 42-residue amyloid-\u03b2. J. Am. Chem. Soc. 146, 24426\u201324439 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"867_CR30","doi-asserted-by":"publisher","first-page":"1120416","DOI":"10.3389\/fmolb.2023.1120416","volume":"10","author":"M Muschol","year":"2023","unstructured":"Muschol, M. & Hoyer, W. Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils. Front. Mol. Biosci. 10, 1120416 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"867_CR31","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1039\/C9SC06501F","volume":"11","author":"AJ Dear","year":"2020","unstructured":"Dear, A. J. et al. Identification of on- and off-pathway oligomers in amyloid fibril formation. Chem. Sci. 11, 6236\u20136247 (2020). This study provides a method to identify and characterize on- and off-pathway A\u03b2Os, offering key mechanistic insight into the distinct routes of fibril formation.","journal-title":"Chem. Sci."},{"key":"867_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41557-020-0452-1","volume":"12","author":"TCT Michaels","year":"2020","unstructured":"Michaels, T. C. T. et al. Dynamics of oligomer populations formed during the aggregation of Alzheimer\u2019s A\u03b242 peptide. Nat. Chem. 12, 445\u2013451 (2020).","journal-title":"Nat. Chem."},{"key":"867_CR33","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1021\/acsomega.4c05527","volume":"10","author":"R Reddi Sree","year":"2025","unstructured":"Reddi Sree, R. et al. Newer therapeutic approaches in treating Alzheimer\u2019s disease: a comprehensive review. ACS Omega 10, 5148\u20135171 (2025).","journal-title":"ACS Omega"},{"key":"867_CR34","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/acschemneuro.4c00246","volume":"15","author":"K Singh","year":"2024","unstructured":"Singh, K., Kaur, A., Goyal, B. & Goyal, D. Harnessing the therapeutic potential of peptides for synergistic treatment of Alzheimer\u2019s disease by targeting A\u03b2 aggregation, metal-mediated A\u03b2 aggregation, cholinesterase, tau degradation, and oxidative stress. ACS Chem. Neurosci. 15, 2545\u20132564 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuroscience.2025.10.011","volume":"589","author":"SA Elamin","year":"2025","unstructured":"Elamin, S. A. et al. Anti-amyloid monoclonal antibody therapies in Alzheimer\u2019s disease \u2013 a scoping review. Neuroscience 589, 50\u201361 (2025).","journal-title":"Neuroscience"},{"key":"867_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41570-021-00254-9","volume":"5","author":"K Kulenkampff","year":"2021","unstructured":"Kulenkampff, K., Wolf Perez, A. M., Sormanni, P., Habchi, J. & Vendruscolo, M. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases. Nat. Rev. Chem. 5, 277\u2013294 (2021).","journal-title":"Nat. Rev. Chem."},{"key":"867_CR37","doi-asserted-by":"publisher","first-page":"12254","DOI":"10.1021\/acs.chemrev.3c00494","volume":"123","author":"Y Bai","year":"2023","unstructured":"Bai, Y. et al. Advanced techniques for detecting protein misfolding and aggregation in cellular environments. Chem. Rev. 123, 12254\u201312311 (2023).","journal-title":"Chem. Rev."},{"key":"867_CR38","doi-asserted-by":"publisher","first-page":"125311","DOI":"10.1016\/j.talanta.2023.125311","volume":"268","author":"H Gao","year":"2024","unstructured":"Gao, H., Chen, J., Huang, Y. & Zhao, R. Advances in targeted tracking and detection of soluble amyloid-\u03b2 aggregates as a biomarker of Alzheimer\u2019s disease. Talanta 268, 125311 (2024).","journal-title":"Talanta"},{"key":"867_CR39","doi-asserted-by":"publisher","first-page":"927530","DOI":"10.3389\/fnmol.2022.927530","volume":"15","author":"H Yang","year":"2022","unstructured":"Yang, H. et al. Based on molecular structures: amyloid-\u03b2 generation, clearance, toxicity and therapeutic strategies. Front. Mol. Neurosci. 15, 927530 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"867_CR40","first-page":"1","volume":"21","author":"YR Huang","year":"2020","unstructured":"Huang, Y. R. & Liu, R. T. The toxicity and polymorphism of \u03b2-amyloid oligomers. Int. J. Mol. Sci. 21, 1\u201319 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesn\u00e9","year":"2006","unstructured":"Lesn\u00e9, S. et al. A specific amyloid-\u03b2 protein assembly in the brain impairs memory (retracted 2024). Nature 440, 352\u2013357 (2006).","journal-title":"Nature"},{"key":"867_CR42","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-024-07691-8","volume":"631","author":"S Lesn\u00e9","year":"2024","unstructured":"Lesn\u00e9, S. et al. Retraction Note: a specific amyloid-\u03b2 protein assembly in the brain impairs memory. Nature 631, 240 (2024).","journal-title":"Nature"},{"key":"867_CR43","doi-asserted-by":"publisher","DOI":"10.1017\/S0033583520000086","volume":"53","author":"J Wu","year":"2020","unstructured":"Wu, J., Cao, C., Loch, R. A., Tiiman, A. & Luo, J. Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives. Q. Rev. Biophys. 53, e12 (2020). This review highlights single-molecule approaches, including single-molecule fluorescence imaging, single-molecule force spectroscopy and single-nanopore electrical recording, that have advanced understanding of amyloid protein oligomers and their potential diagnostic applications.","journal-title":"Q. Rev. Biophys."},{"key":"867_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biophysica2020010","volume":"2","author":"D Shea","year":"2022","unstructured":"Shea, D. & Daggett, V. Amyloid-\u03b2 oligomers: multiple moving targets. Biophysica 2, 91\u2013110 (2022).","journal-title":"Biophysica"},{"key":"867_CR45","doi-asserted-by":"publisher","first-page":"15157","DOI":"10.1021\/bi061850f","volume":"45","author":"RW Hepler","year":"2006","unstructured":"Hepler, R. W. et al. Solution state characterization of amyloid \u03b2-derived diffusible ligands. Biochem 45, 15157\u201315167 (2006).","journal-title":"Biochem"},{"key":"867_CR46","doi-asserted-by":"publisher","first-page":"462024","DOI":"10.1016\/j.chroma.2021.462024","volume":"1643","author":"IC Fontana","year":"2021","unstructured":"Fontana, I. C. et al. Rapid size-exclusion high performance liquid chromatography method for the quality control of amyloid-\u03b2 oligomers. J. Chromatogr. A 1643, 462024 (2021).","journal-title":"J. Chromatogr. A"},{"key":"867_CR47","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3390\/ijms13033038","volume":"13","author":"NE Pryor","year":"2012","unstructured":"Pryor, N. E., Moss, M. A. & Hestekin, C. N. Unraveling the early events of amyloid-\u03b2 protein (A\u03b2) aggregation: techniques for the determination of A\u03b2 aggregate size. Int. J. Mol. Sci. 13, 3038\u20133072 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3233\/JAD-2011-111421","volume":"28","author":"KA Bruggink","year":"2012","unstructured":"Bruggink, K. A., M\u00fcller, M., Kuiperij, H. B. & Verbeek, M. M. Methods for analysis of amyloid-\u03b2 aggregates. J. Alzheimer\u2019s Dis. 28, 735\u2013758 (2012).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"867_CR49","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1021\/ac400023c","volume":"85","author":"JT Pedersen","year":"2013","unstructured":"Pedersen, J. T. & Heegaard, N. H. H. Analysis of protein aggregation in neurodegenerative disease. Anal. Chem. 85, 4215\u20134227 (2013).","journal-title":"Anal. Chem."},{"key":"867_CR50","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1073\/pnas.1820585116","volume":"116","author":"D Shea","year":"2019","unstructured":"Shea, D. et al. \u03b1-Sheet secondary structure in amyloid \u03b2-peptide drives aggregation and toxicity in Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 116, 8895\u20138900 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/alzrt226","volume":"5","author":"EY Hayden","year":"2013","unstructured":"Hayden, E. Y. & Teplow, D. B. Amyloid \u03b2-protein oligomers and Alzheimer\u2019s disease. Alzheimer\u2019s Res. Ther. 5, 60 (2013).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"867_CR52","doi-asserted-by":"publisher","first-page":"106505","DOI":"10.1016\/j.bpc.2020.106505","volume":"268","author":"EE Cawood","year":"2021","unstructured":"Cawood, E. E., Karamanos, T. K., Wilson, A. J. & Radford, S. E. Visualizing and trapping transient oligomers in amyloid assembly pathways. Biophys. Chem. 268, 106505 (2021).","journal-title":"Biophys. Chem."},{"key":"867_CR53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jnc.15466","volume":"159","author":"W Michno","year":"2021","unstructured":"Michno, W., Blennow, K., Zetterberg, H. & Brinkmalm, G. Refining the amyloid \u03b2 peptide and oligomer fingerprint ambiguities in Alzheimer\u2019s disease: mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma. J. Neurochem. 159, 234\u2013257 (2021).","journal-title":"J. Neurochem."},{"key":"867_CR54","doi-asserted-by":"publisher","first-page":"10440","DOI":"10.1021\/jacs.9b04596","volume":"141","author":"N \u00d6sterlund","year":"2019","unstructured":"\u00d6sterlund, N., Moons, R., Ilag, L. L., Sobott, F. & Graslund, A. Native ion mobility-mass spectrometry reveals the formation of \u03b2-barrel shaped amyloid-\u03b2 hexamers in a membrane-mimicking environment. J. Am. Chem. Soc. 141, 10440\u201310450 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"867_CR55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fchem.2020.00324","volume":"8","author":"J Hu","year":"2020","unstructured":"Hu, J. & Zheng, Q. Applications of mass spectrometry in the onset of amyloid fibril formation: focus on the analysis of early-stage oligomers. Front. Chem. 8, 324 (2020).","journal-title":"Front. Chem."},{"key":"867_CR56","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/mas.21814","volume":"43","author":"WJ Wagner","year":"2024","unstructured":"Wagner, W. J. & Gross, M. L. Using mass spectrometry-based methods to understand amyloid formation and inhibition of alpha-synuclein and amyloid beta. Mass. Spectrom. Rev. 43, 782\u2013825 (2024).","journal-title":"Mass. Spectrom. Rev."},{"key":"867_CR57","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1073\/pnas.0905127106","volume":"106","author":"K Ono","year":"2009","unstructured":"Ono, K., Condron, M. M. & Teplow, D. B. Structure-neurotoxicity relationships of amyloid-protein oligomers. Proc. Natl Acad. Sci. USA 106, 14745\u201314750 (2009). This study correlates the structural properties of A\u03b2Os with their neurotoxicity using multiple biophysical and cellular assays, providing key insights into the pathogenic features of amyloid assemblies.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ab.2016.10.026","volume":"518","author":"EY Hayden","year":"2016","unstructured":"Hayden, E. Y., Conovaloff, J. L., Mason, A., Bitan, G. & Teplow, D. B. Preparation of pure populations of covalently stabilized amyloid \u03b2-protein oligomers of specific sizes. Anal. Biochem. 518, 78\u201385 (2016).","journal-title":"Anal. Biochem."},{"key":"867_CR59","doi-asserted-by":"publisher","first-page":"12202","DOI":"10.1021\/acsnano.7b05434","volume":"11","author":"S Banerjee","year":"2017","unstructured":"Banerjee, S., Sun, Z., Hayden, E. Y., Teplow, D. B. & Lyubchenko, Y. L. Nanoscale dynamics of amyloid \u03b2-42 oligomers as revealed by high-speed atomic force microscopy. ACS Nano 11, 12202\u201312209 (2017). This work visualizes the dynamic behaviour of cross-linked A\u03b2\u2081\u208b\u2084\u2082 trimers, pentamers, and heptamers at nanometre resolution and millisecond timescales, revealing critical aspects of oligomer formation and stability.","journal-title":"ACS Nano"},{"key":"867_CR60","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1021\/ac301198c","volume":"84","author":"GW Preston","year":"2012","unstructured":"Preston, G. W., Radford, S. E., Ashcroft, A. E. & Wilson, A. J. Covalent cross-linking within supramolecular peptide structures. Anal. Chem. 84, 6790\u20136797 (2012).","journal-title":"Anal. Chem."},{"key":"867_CR61","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1039\/c3cs35459h","volume":"42","author":"GW Preston","year":"2013","unstructured":"Preston, G. W. & Wilson, A. J. Photo-induced covalent cross-linking for the analysis of biomolecular interactions. Chem. Soc. Rev. 42, 3289\u20133301 (2013).","journal-title":"Chem. Soc. Rev."},{"key":"867_CR62","doi-asserted-by":"publisher","first-page":"8216","DOI":"10.1126\/sciadv.aav8216","volume":"5","author":"SJ Bunce","year":"2019","unstructured":"Bunce, S. J. et al. Molecular insights into the surface-catalyzed secondary nucleation of amyloid-\u03b240 (A\u03b240) by the peptide fragment A\u03b216\u201322. Sci. Adv. 5, 8216\u20138237 (2019).","journal-title":"Sci. Adv."},{"key":"867_CR63","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/jnc.14647","volume":"148","author":"EN Cline","year":"2019","unstructured":"Cline, E. N. et al. A novel crosslinking protocol stabilizes amyloid \u03b2 oligomers capable of inducing Alzheimer\u2019s-associated pathologies. J. Neurochem. 148, 822\u2013836 (2019).","journal-title":"J. Neurochem."},{"key":"867_CR64","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin, M. et al. Soluble amyloid \u03b2-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl Acad. Sci. USA 108, 5819\u20135824 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR65","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott, B. et al. A vicious cycle of b amyloid-dependent neuronal hyperactivation. Science 365, 559\u2013565 (2019).","journal-title":"Science"},{"key":"867_CR66","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/brain\/awz082","volume":"142","author":"RJ Bateman","year":"2019","unstructured":"Bateman, R. J., Mawuenyega, K. G. & Wildburger, N. C. The structure of amyloid-\u03b2 dimers in Alzheimer\u2019s disease brain: a step forward for oligomers. Brain 142, 1168\u20131169 (2019).","journal-title":"Brain"},{"key":"867_CR67","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1039\/D3OB00509G","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Chen, J., Gao, F., Hu, M. & Wang, X. Recent developments in the chemical biology of amyloid-\u03b2 oligomer targeting. Org. Biomol. Chem. 21, 4540\u20134552 (2023).","journal-title":"Org. Biomol. Chem."},{"key":"867_CR68","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/appliedchem5040035","volume":"5","author":"NJ Ayon","year":"2025","unstructured":"Ayon, N. J. Preanalytical strategies for native mass spectrometry analysis of protein modifications, complexes, and higher-order structures. AppliedChem 5, 35 (2025).","journal-title":"AppliedChem"},{"key":"867_CR69","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1021\/ja044531p","volume":"127","author":"SL Bernstein","year":"2005","unstructured":"Bernstein, S. L. et al. Amyloid \u03b2-protein: monomer structure and early aggregation states of A\u03b242 and its Pro19 alloform. J. Am. Chem. Soc. 127, 2075\u20132084 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"867_CR70","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nchem.247","volume":"1","author":"SL Bernstein","year":"2009","unstructured":"Bernstein, S. L. et al. Amyloid-\u03b2 2 protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer\u2019s disease. Nat. Chem. 1, 326\u2013331 (2009). This paper uses ion-mobility mass spectrometry to characterize tetrameric and dodecameric A\u03b2\u2081\u208b\u2084\u2082 oligomers, implicating these species as important intermediates in amyloid assembly relevant to Alzheimer disease.","journal-title":"Nat. Chem."},{"key":"867_CR71","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1021\/ja8092604","volume":"131","author":"MM Murray","year":"2009","unstructured":"Murray, M. M. et al. Amyloid \u03b2 protein: A\u03b240 inhibits A\u03b242 oligomerization. J. Am. Chem. Soc. 131, 6316\u20136317 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"867_CR72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jmb.2011.01.012","volume":"407","author":"M K\u0142oniecki","year":"2011","unstructured":"K\u0142oniecki, M. et al. Ion mobility separation coupled with MS detects two structural states of Alzheimer\u2019s disease A\u03b21\u201340 peptide oligomers. J. Mol. Biol. 407, 110\u2013124 (2011).","journal-title":"J. Mol. Biol."},{"key":"867_CR73","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1021\/acschemneuro.4c00492","volume":"15","author":"T Habeck","year":"2024","unstructured":"Habeck, T. et al. Cross-interactions of A\u03b2 peptides implicated in Alzheimer\u2019s disease shape amyloid oligomer structures and aggregation. ACS Chem. Neurosci. 15, 4295\u20134304 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR74","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.1523\/JNEUROSCI.3916-08.2008","volume":"28","author":"LW Hung","year":"2008","unstructured":"Hung, L. W. et al. Amyloid-\u03b2 peptide (A\u03b2) neurotoxicity is modulated by the rate of peptide aggregation: A\u03b2 dimers and trimers correlate with neurotoxicity. J. Neurosci. 28, 11950\u201311958 (2008).","journal-title":"J. Neurosci."},{"key":"867_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pbiomolbio.2024.01.002","volume":"187","author":"A Nutini","year":"2024","unstructured":"Nutini, A. Amyloid oligomers and their membrane toxicity \u2013 a perspective study. Prog. Biophys. Mol. Biol. 187, 9\u201320 (2024).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"867_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202215785","volume":"62","author":"JH Viles","year":"2023","unstructured":"Viles, J. H. Imaging amyloid-\u03b2 membrane interactions: ion-channel pores and lipid-bilayer permeability in Alzheimer\u2019s disease. Angew. Chem. Int. Ed. 62, e202215785 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"867_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16566-1","volume":"11","author":"S Ciudad","year":"2020","unstructured":"Ciudad, S. et al. A\u03b2(1\u201342) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage. Nat. Commun. 11, 3014 (2020).","journal-title":"Nat. Commun."},{"key":"867_CR78","doi-asserted-by":"publisher","first-page":"18340","DOI":"10.1021\/jacs.3c03980","volume":"145","author":"M Khaled","year":"2023","unstructured":"Khaled, M. et al. A hairpin motif in the amyloid-\u03b2 peptide is important for formation of disease-related oligomers. J. Am. Chem. Soc. 145, 18340\u201318354 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"867_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mas.21775","volume":"44","author":"NV Zakharova","year":"2025","unstructured":"Zakharova, N. V. et al. Mass spectrometric studies of the variety of beta-amyloid proteoforms in Alzheimer\u2019s disease. Mass. Spectrom. Rev. 44, 3\u201321 (2025).","journal-title":"Mass. Spectrom. Rev."},{"key":"867_CR80","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1021\/jacs.6b11748","volume":"139","author":"AG Kreutzer","year":"2017","unstructured":"Kreutzer, A. G., Yoo, S., Spencer, R. K. & Nowick, J. S. Stabilization, assembly, and toxicity of trimers derived from A\u03b2. J. Am. Chem. Soc. 139, 966\u2013975 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"867_CR81","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1039\/D3SC05185D","volume":"15","author":"TD Samdin","year":"2024","unstructured":"Samdin, T. D. et al. A \u03b2-barrel-like tetramer formed by a \u03b2-hairpin derived from A\u03b2. Chem. Sci. 15, 285\u2013297 (2024).","journal-title":"Chem. Sci."},{"key":"867_CR82","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1021\/acs.biochem.1c00739","volume":"61","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. A disulfide-stabilized A\u03b2 that forms dimers but does not form fibrils. Biochem 61, 252\u2013264 (2022).","journal-title":"Biochem"},{"key":"867_CR83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219216120","volume":"120","author":"AG Kreutzer","year":"2023","unstructured":"Kreutzer, A. G. et al. Probing differences among A\u03b2 oligomers with two triangular trimers derived from A\u03b2. Proc. Natl Acad. Sci. USA 120, e2219216120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR84","doi-asserted-by":"publisher","DOI":"10.2142\/biophysico.bppb-v20.0007","volume":"20","author":"H Hiroaki","year":"2023","unstructured":"Hiroaki, H. Molecular mechanisms of amyloid-\u03b2 peptide fibril and oligomer formation: NMR-based challenges. Biophys. Physicobiol. 20, e200007 (2023).","journal-title":"Biophys. Physicobiol."},{"key":"867_CR85","doi-asserted-by":"publisher","first-page":"13049","DOI":"10.3390\/ijms252313049","volume":"25","author":"O Cehlar","year":"2024","unstructured":"Cehlar, O. et al. Structures of oligomeric states of tau protein, amyloid-\u03b2, \u03b1-synuclein and prion protein implicated in Alzheimer\u2019s disease, Parkinson\u2019s disease and prionopathies. Int. J. Mol. Sci. 25, 13049 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR86","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1039\/D0CC01551B","volume":"56","author":"BR Sahoo","year":"2020","unstructured":"Sahoo, B. R., Cox, S. J. & Ramamoorthy, A. High-resolution probing of early events in amyloid-\u03b2 aggregation related to Alzheimer\u2019s disease. Chem. Commun. 56, 4627\u20134639 (2020).","journal-title":"Chem. Commun."},{"key":"867_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/srep11811","volume":"5","author":"SA Kotler","year":"2015","unstructured":"Kotler, S. A. et al. High-resolution NMR characterization of low abundance oligomers of amyloid-\u03b2 without purification. Sci. Rep. 5, 11811 (2015).","journal-title":"Sci. Rep."},{"key":"867_CR88","doi-asserted-by":"publisher","first-page":"8526","DOI":"10.1039\/D2SC01555B","volume":"13","author":"HW Chang","year":"2022","unstructured":"Chang, H. W. et al. Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers. Chem. Sci. 13, 8526\u20138535 (2022).","journal-title":"Chem. Sci."},{"key":"867_CR89","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1021\/bi802046n","volume":"48","author":"L Yu","year":"2009","unstructured":"Yu, L. et al. Structural characterization of a soluble amyloid \u03b2-peptide oligomer. Biochem 48, 1870\u20131877 (2009).","journal-title":"Biochem"},{"key":"867_CR90","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.abm7285","volume":"375","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. Cryo-EM structures of amyloid-\u03b2 42 filaments from human brain. Science. 375, 167\u2013172 (2021).","journal-title":"Science."},{"key":"867_CR91","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1039\/D2FD00034B","volume":"240","author":"S L\u00f6vestam","year":"2022","unstructured":"L\u00f6vestam, S. & Scheres, S. H. W. High-throughput cryo-EM structure determination of amyloids. Faraday Discuss. 240, 243\u2013260 (2022).","journal-title":"Faraday Discuss."},{"key":"867_CR92","doi-asserted-by":"publisher","first-page":"eadx9030","DOI":"10.1126\/sciadv.adx9030","volume":"11","author":"R Liang","year":"2025","unstructured":"Liang, R. et al. Amyloid-\u03b2 oligomers, curvilinear and annular assemblies, imaged by cryo-ET, cryo-EM, and AFM. Sci. Adv. 11, eadx9030 (2025).","journal-title":"Sci. Adv."},{"key":"867_CR93","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s40478-023-01694-8","volume":"11","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Cryo-EM structures of A\u03b240 filaments from the leptomeninges of individuals with Alzheimer\u2019s disease and cerebral amyloid angiopathy. Acta Neuropathol. Commun. 11, 191 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"867_CR94","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.jbc.2021.100938","volume":"297","author":"M Zielinski","year":"2021","unstructured":"Zielinski, M., R\u00f6der, C. & Schr\u00f6der, G. F. Challenges in sample preparation and structure determination of amyloids by cryo-EM. J. Biol. Chem. 297, 100938 (2021).","journal-title":"J. Biol. Chem."},{"key":"867_CR95","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature20416","volume":"539","author":"R Riek","year":"2016","unstructured":"Riek, R. & Eisenberg, D. S. The activities of amyloids from a structural perspective. Nature 539, 227\u2013235 (2016).","journal-title":"Nature"},{"key":"867_CR96","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/molecules26040948","volume":"26","author":"J Yang","year":"2021","unstructured":"Yang, J., Perrett, S. & Wu, S. Single molecule characterization of amyloid oligomers. Molecules 26, 948 (2021).","journal-title":"Molecules"},{"key":"867_CR97","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.1074\/jbc.M210207200","volume":"278","author":"WB Stine","year":"2003","unstructured":"Stine, W. B., Dahlgren, K. N., Krafft, G. A. & LaDu, M. J. In vitro characterization of conditions for amyloid-\u03b2 peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612\u201311622 (2003). This work shows an early study to use unaggregated homogeneous starting materials and demonstrates that formation of small A\u03b21\u201342 oligomers correlates with neuronal toxicity, clarifying how oligomer size influences pathogenicity.","journal-title":"J. Biol. Chem."},{"key":"867_CR98","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1021\/acs.analchem.9b01316","volume":"91","author":"J Yoon","year":"2019","unstructured":"Yoon, J., Kim, Y. & Park, J. W. Binary structure of amyloid beta oligomers revealed by dual recognition mapping. Anal. Chem. 91, 8422\u20138428 (2019).","journal-title":"Anal. Chem."},{"key":"867_CR99","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1096\/fj.01-0377com","volume":"15","author":"H Lin","year":"2001","unstructured":"Lin, H., Bhatia, R. & Lal, R. Amyloid \u03b2 protein forms ion channels: implications for Alzheimer\u2019s disease pathophysiology. FASEB J. 15, 2433\u20132444 (2001).","journal-title":"FASEB J."},{"key":"867_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21124287","volume":"21","author":"T Watanabe-Nakayama","year":"2020","unstructured":"Watanabe-Nakayama, T., Sahoo, B. R., Ramamoorthy, A. & Ono, K. High-speed atomic force microscopy reveals the structural dynamics of the amyloid-\u03b2 and amylin aggregation pathways. Int. J. Mol. Sci. 21, 1\u201330 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR101","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1073\/pnas.1524807113","volume":"113","author":"T Watanabe-Nakayama","year":"2016","unstructured":"Watanabe-Nakayama, T. et al. High-speed atomic force microscopy reveals structural dynamics of amyloid \u03b21\u201342 aggregates. Proc. Natl Acad. Sci. USA 113, 5835\u20135840 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR102","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fmolb.2020.00069","volume":"7","author":"S Maity","year":"2020","unstructured":"Maity, S. & Lyubchenko, Y. L. AFM probing of amyloid-beta 42 dimers and trimers. Front. Mol. Biosci. 7, 69 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"867_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/srep02880","volume":"3","author":"Z Lv","year":"2013","unstructured":"Lv, Z., Roychaudhuri, R., Condron, M. M., Teplow, D. B. & Lyubchenko, Y. L. Mechanism of amyloid \u03b2-protein dimerization determined using single-molecule AMF force spectroscopy. Sci. Rep. 3, 2880 (2013).","journal-title":"Sci. Rep."},{"key":"867_CR104","doi-asserted-by":"publisher","first-page":"16387","DOI":"10.1039\/C7CP02691A","volume":"19","author":"S Maity","year":"2017","unstructured":"Maity, S., Viazovkina, E., Gall, A. & Lyubchenko, Y. L. Single-molecule probing of amyloid nano-ensembles using the polymer nanoarray approach. Phys. Chem. Chem. Phys. 19, 16387\u201316394 (2017).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"867_CR105","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.nano.2013.11.016","volume":"10","author":"BH Kim","year":"2014","unstructured":"Kim, B. H. & Lyubchenko, Y. L. Nanoprobing of misfolding and interactions of amyloid \u03b2 42 protein. Nanomedicine 10, 871\u2013878 (2014).","journal-title":"Nanomedicine"},{"key":"867_CR106","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/bios12121116","volume":"12","author":"F Xia","year":"2022","unstructured":"Xia, F. & Youcef-Toumi, K. Advanced atomic force microscopy modes for biomedical research. Biosensors 12, 1116 (2022).","journal-title":"Biosensors"},{"key":"867_CR107","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.abb.2019.02.001","volume":"664","author":"FS Ruggeri","year":"2019","unstructured":"Ruggeri, F. S., \u0160neideris, T., Vendruscolo, M. & Knowles, T. P. J. Atomic force microscopy for single molecule characterisation of protein aggregation. Arch. Biochem. Biophys. 664, 134\u2013148 (2019).","journal-title":"Arch. Biochem. Biophys."},{"key":"867_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/pro.70151","volume":"34","author":"A Kalitnik","year":"2025","unstructured":"Kalitnik, A. et al. Experimental methods for studying amyloid cross-interactions. Protein Sci. 34, e70151 (2025).","journal-title":"Protein Sci."},{"key":"867_CR109","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bpj.2017.12.025","volume":"114","author":"F Meng","year":"2018","unstructured":"Meng, F. et al. Highly disordered amyloid-\u03b2 monomer probed by single-molecule FRET and MD simulation. Biophys. J. 114, 870\u2013884 (2018). This work applies single-molecule F\u00f6rster resonance energy transfer and molecular diffusion analysis to resolve stable, low-population A\u03b2\u2081\u208b\u2084\u2082 oligomers and multiple aggregation states at the single-molecule level.","journal-title":"Biophys. J."},{"key":"867_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/pnasnexus\/pgad253","volume":"2","author":"F Meng","year":"2023","unstructured":"Meng, F., Kim, J. Y., Gopich, I. V. & Chung, H. S. Single-molecule FRET and molecular diffusion analysis characterize stable oligomers of amyloid-\u03b2 42 of extremely low population. PNAS Nexus 2, 1\u201314 (2023).","journal-title":"PNAS Nexus"},{"key":"867_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/srep28658","volume":"6","author":"M Iljina","year":"2016","unstructured":"Iljina, M. et al. Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms. Sci. Rep. 6, 28658 (2016).","journal-title":"Sci. Rep."},{"key":"867_CR112","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/ijms19040964","volume":"19","author":"A Kitamura","year":"2013","unstructured":"Kitamura, A. & Kinjo, M. State-of-the-art fluorescence fluctuation-based spectroscopic techniques for the study of protein aggregation. Int. J. Mol. Sci. 19, 964 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR113","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fphys.2013.00084","volume":"4","author":"B Sarkar","year":"2013","unstructured":"Sarkar, B., Das, A. K. & Maiti, S. Thermodynamically stable amyloid-\u03b2 monomers have much lower membrane affinity than the small oligomers. Front. Physiol. 4, 84 (2013).","journal-title":"Front. Physiol."},{"key":"867_CR114","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.yexmp.2007.01.008","volume":"82","author":"S Hossain","year":"2007","unstructured":"Hossain, S., Grande, M., Ahmadkhanov, G. & Pramanik, A. Binding of the Alzheimer amyloid \u03b2-peptide to neuronal cell membranes by fluorescence correlation spectroscopy. Exp. Mol. Pathol. 82, 169\u2013174 (2007).","journal-title":"Exp. Mol. Pathol."},{"key":"867_CR115","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1074-5521(99)80020-9","volume":"6","author":"LO Tjernberg","year":"1999","unstructured":"Tjernberg, L. O. et al. Amyloid \u03b2-peptide polymerization studied using fluorescence correlation spectroscopy. Chem. Biol. 6, 53\u201362 (1999).","journal-title":"Chem. Biol."},{"key":"867_CR116","doi-asserted-by":"publisher","first-page":"10506","DOI":"10.1021\/bi0341410","volume":"42","author":"P Sengupta","year":"2003","unstructured":"Sengupta, P. et al. The amyloid \u03b2 peptide (A\u03b21\u201340) is thermodynamically soluble at physiological concentrations. Biochem 42, 10506\u201310513 (2003).","journal-title":"Biochem"},{"key":"867_CR117","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/protein\/gzm054","volume":"21","author":"K Wiesehan","year":"2008","unstructured":"Wiesehan, K. et al. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer\u2019s disease amyloid peptide. Protein Eng. Des. Sel. 21, 241\u2013246 (2008).","journal-title":"Protein Eng. Des. Sel."},{"key":"867_CR118","doi-asserted-by":"publisher","first-page":"11700","DOI":"10.1021\/acs.analchem.5b02630","volume":"87","author":"S Wennmalm","year":"2015","unstructured":"Wennmalm, S., Chmyrov, V., Widengren, J. & Tjernberg, L. Highly sensitive FRET\u2013FCS detects amyloid \u03b2-peptide oligomers in solution at physiological concentrations. Anal. Chem. 87, 11700\u201311705 (2015). This paper demonstrates, for the first time, direct detection of A\u03b2 oligomers at physiological concentrations using F\u00f6rster resonance energy transfer\u2013fluorescence correlation spectroscopy.","journal-title":"Anal. Chem."},{"key":"867_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19961-3","volume":"8","author":"M Novo","year":"2018","unstructured":"Novo, M., Freire, S. & Al-Soufi, W. Critical aggregation concentration for the formation of early amyloid-\u03b2 (1\u201342) oligomers. Sci. Rep. 8, 1783 (2018).","journal-title":"Sci. Rep."},{"key":"867_CR120","doi-asserted-by":"publisher","first-page":"110179","DOI":"10.1016\/j.abb.2024.110179","volume":"761","author":"S Illodo","year":"2024","unstructured":"Illodo, S., Al-Soufi, W. & Novo, M. Critical aggregation concentration and reversibility of amyloid-\u03b2 (1\u201340) oligomers. Arch. Biochem. Biophys. 761, 110179 (2024).","journal-title":"Arch. Biochem. Biophys."},{"key":"867_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/bip.23237","volume":"109","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y. et al. The effects of fluorescent labels on A\u03b2 42 aggregation detected by fluorescence correlation spectroscopy. Biopolymers 109, e23237 (2018).","journal-title":"Biopolymers"},{"key":"867_CR122","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/biophysica2040043","volume":"2","author":"D Polanco","year":"2022","unstructured":"Polanco, D., Carrancho, A., Gracia, P. & Cremades, N. Characterisation of amyloid aggregation and inhibition by diffusion-based single-molecule fluorescence techniques. Biophysica 2, 506\u2013524 (2022).","journal-title":"Biophysica"},{"key":"867_CR123","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.bpj.2009.05.035","volume":"97","author":"H Ding","year":"2009","unstructured":"Ding, H., Wong, P. T., Lee, E. L., Gafni, A. & Steel, D. G. Determination of the oligomer size of amyloidogenic protein \u03b2-amyloid(1\u201340) by single-molecule spectroscopy. Biophys. J. 97, 912\u2013921 (2009).","journal-title":"Biophys. J."},{"key":"867_CR124","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ymeth.2020.06.007","volume":"193","author":"L Dresser","year":"2021","unstructured":"Dresser, L. et al. Amyloid-\u03b2 oligomerization monitored by single-molecule stepwise photobleaching. Methods 193, 80\u201395 (2021).","journal-title":"Methods"},{"key":"867_CR125","doi-asserted-by":"publisher","first-page":"967882","DOI":"10.3389\/fchem.2022.967882","volume":"10","author":"B Tahirbegi","year":"2022","unstructured":"Tahirbegi, B. et al. Toward high-throughput oligomer detection and classification for early-stage aggregation of amyloidogenic protein. Front. Chem. 10, 967882 (2022).","journal-title":"Front. Chem."},{"key":"867_CR126","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1021\/acs.jpclett.4c01048","volume":"15","author":"A Dey","year":"2024","unstructured":"Dey, A., Patil, A., Arumugam, S. & Maiti, S. Single-molecule maps of membrane insertion by amyloid-\u03b2 oligomers predict their toxicity. J. Phys. Chem. Lett. 15, 6292\u20136298 (2024).","journal-title":"J. Phys. Chem. Lett."},{"key":"867_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09477-3","volume":"10","author":"S De","year":"2019","unstructured":"De, S. et al. Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms. Nat. Commun. 10, 1541 (2019). This work uses atomic force microscopy imaging to follow aggregation and shows that distinct A\u03b21\u201342 oligomers induce toxicity via separate pathways, highlighting mechanistic diversity among soluble aggregates.","journal-title":"Nat. Commun."},{"key":"867_CR128","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.bpj.2012.08.051","volume":"103","author":"H Ding","year":"2012","unstructured":"Ding, H., Schauerte, J. A., Steel, D. G. & Gafni, A. \u03b2-Amyloid (1\u201340) peptide interactions with supported phospholipid membranes: a single-molecule study. Biophys. J. 103, 1500\u20131509 (2012).","journal-title":"Biophys. J."},{"key":"867_CR129","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.bpj.2018.12.010","volume":"116","author":"J W\u00e4gele","year":"2019","unstructured":"W\u00e4gele, J., De Sio, S., Voigt, B., Balbach, J. & Ott, M. How fluorescent tags modify oligomer size distributions of the Alzheimer peptide. Biophys. J. 116, 227\u2013238 (2019).","journal-title":"Biophys. J."},{"key":"867_CR130","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41570-025-00694-7","volume":"9","author":"RI Horne","year":"2025","unstructured":"Horne, R. I., Sandler, S. E., Vendruscolo, M. & Keyser, U. F. Detection of protein oligomers with nanopores. Nat. Rev. Chem. 9, 224\u2013240 (2025). This review surveys nanopore-based single-molecule approaches for detecting protein oligomers, highlighting their utility for characterizing transient and heterogeneous species such as A\u03b2 oligomers.","journal-title":"Nat. Rev. Chem."},{"key":"867_CR131","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/ac1029874","volume":"83","author":"HY Wang","year":"2011","unstructured":"Wang, H. Y., Ying, Y. L., Li, Y., Kraatz, H. B. & Long, Y. T. Nanopore analysis of \u03b2-amyloid peptide aggregation transition induced by small molecules. Anal. Chem. 83, 1746\u20131752 (2011).","journal-title":"Anal. Chem."},{"key":"867_CR132","doi-asserted-by":"publisher","first-page":"129863","DOI":"10.1016\/j.snb.2021.129863","volume":"338","author":"B Lenhart","year":"2021","unstructured":"Lenhart, B. et al. In vitro biosensing of \u03b2-amyloid peptide aggregation dynamics using a biological nanopore. Sens. Actuators B 338, 129863 (2021).","journal-title":"Sens. Actuators B"},{"key":"867_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/asia.202200726","volume":"17","author":"I Abrao-Nemeir","year":"2022","unstructured":"Abrao-Nemeir, I. et al. Investigation of \u03b1-synuclein and amyloid-\u03b2(42)-E22\u0394 oligomers using SiN nanopore functionalized with L-dopa. Chem. Asian J. 17, e202200726 (2022).","journal-title":"Chem. Asian J."},{"key":"867_CR134","doi-asserted-by":"publisher","first-page":"12623","DOI":"10.1021\/acs.analchem.3c00017","volume":"95","author":"N Meyer","year":"2023","unstructured":"Meyer, N. et al. Ultrasensitive detection of A\u03b242 seeds in cerebrospinal fluid with a nanopipette-based real-time fast amyloid seeding and translocation assay. Anal. Chem. 95, 12623\u201312630 (2023).","journal-title":"Anal. Chem."},{"key":"867_CR135","doi-asserted-by":"publisher","first-page":"106533","DOI":"10.1016\/j.bpc.2020.106533","volume":"270","author":"F Grigolato","year":"2021","unstructured":"Grigolato, F. & Arosio, P. The role of surfaces on amyloid formation. Biophys. Chem. 270, 106533 (2021).","journal-title":"Biophys. Chem."},{"key":"867_CR136","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","volume":"121","author":"PH Nguyen","year":"2021","unstructured":"Nguyen, P. H. et al. Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, type II diabetes, and amyotrophic lateral sclerosis. Chem. Rev. 121, 2545\u20132647 (2021).","journal-title":"Chem. Rev."},{"key":"867_CR137","doi-asserted-by":"publisher","first-page":"116684","DOI":"10.1016\/j.ejmech.2024.116684","volume":"276","author":"PB Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves, P. B., Sodero, A. C. R. & Cordeiro, Y. Natural products targeting amyloid-\u03b2 oligomer neurotoxicity in Alzheimer\u2019s disease. Eur. J. Med. Chem. 276, 116684 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"867_CR138","doi-asserted-by":"publisher","first-page":"114828","DOI":"10.1016\/j.ab.2022.114828","volume":"654","author":"KA Young","year":"2022","unstructured":"Young, K. A. & Mancera, R. L. Review: investigating the aggregation of amyloid beta with surface plasmon resonance: do different approaches yield different results? Anal. Biochem. 654, 114828 (2022).","journal-title":"Anal. Biochem."},{"key":"867_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/cplu.202400243","volume":"89","author":"A Palmioli","year":"2024","unstructured":"Palmioli, A. & Airoldi, C. An NMR toolkit to probe amyloid oligomer inhibition in neurodegenerative diseases: from ligand screening to dissecting binding topology and mechanisms of action. ChemPlusChem 89, e202400243 (2024).","journal-title":"ChemPlusChem"},{"key":"867_CR140","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke, J. et al. EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity. Proc. Natl Acad. Sci. USA 107, 7710\u20137715 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR141","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer, D. E. et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558\u2013566 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"867_CR142","doi-asserted-by":"publisher","first-page":"22525","DOI":"10.1039\/D4RA03343D","volume":"14","author":"PB Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves, P. B., Cordeiro, Y. & Renn\u00f3 Sodero, A. C. Understanding the mechanisms of green tea EGCG against amyloid \u03b2 oligomer neurotoxicity through computational studies. RSC Adv. 14, 22525\u201322539 (2024).","journal-title":"RSC Adv."},{"key":"867_CR143","doi-asserted-by":"publisher","first-page":"7893","DOI":"10.1021\/bi500910b","volume":"53","author":"Z Fu","year":"2014","unstructured":"Fu, Z. et al. Capping of A\u03b242 oligomers by small molecule inhibitors. Biochem 53, 7893\u20137903 (2014).","journal-title":"Biochem"},{"key":"867_CR144","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1021\/acschemneuro.5b00214","volume":"7","author":"A Thapa","year":"2016","unstructured":"Thapa, A., Jett, S. D. & Chi, E. Y. Curcumin attenuates amyloid-\u03b2 aggregate toxicity and modulates amyloid-\u03b2 aggregation pathway. ACS Chem. Neurosci. 7, 56\u201368 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR145","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.3390\/ijms23105794","volume":"23","author":"H Russ","year":"2022","unstructured":"Russ, H. et al. The small molecule GAL-201 efficiently detoxifies soluble amyloid \u03b2 oligomers: new approach towards oral disease-modifying treatment of Alzheimer\u2019s disease. Int. J. Mol. Sci. 23, 5794 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR146","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40263-017-0434-z","volume":"31","author":"P Kocis","year":"2017","unstructured":"Kocis, P. et al. Elucidating the A\u03b242 anti-aggregation mechanism of action of tramiprosate in Alzheimer\u2019s disease: integrating molecular analytical methods, pharmacokinetic and clinical data. CNS Drugs 31, 495\u2013509 (2017).","journal-title":"CNS Drugs"},{"key":"867_CR147","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/14656566.2024.2360069","volume":"25","author":"D Lee","year":"2024","unstructured":"Lee, D., Antonsdottir, I. M., Clark, E. D. & Porsteinsson, A. P. Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer\u2019s disease: a novel small molecule with disease modifying potential. Expert. Opin. Pharmacother. 25, 791\u2013799 (2024).","journal-title":"Expert. Opin. Pharmacother."},{"key":"867_CR148","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402622R","volume":"39","author":"D Muramatsu","year":"2025","unstructured":"Muramatsu, D. et al. ALZ-801 prevents amyloid \u03b2-protein assembly and reduces cytotoxicity: a preclinical experimental study. FASEB J. 39, e70382 (2025).","journal-title":"FASEB J."},{"key":"867_CR149","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/pro.3906","volume":"29","author":"J Fantini","year":"2020","unstructured":"Fantini, J., Chahinian, H. & Yahi, N. Progress toward Alzheimer\u2019s disease treatment: leveraging the Achilles\u2019 heel of A\u03b2 oligomers? Protein Sci. 29, 1748\u20131759 (2020).","journal-title":"Protein Sci."},{"key":"867_CR150","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1039\/D4MD00729H","volume":"16","author":"N Sehra","year":"2024","unstructured":"Sehra, N., Parmar, R. & Jain, R. Peptide-based amyloid-beta aggregation inhibitors. RSC Med. Chem. 16, 1083\u20131104 (2024).","journal-title":"RSC Med. Chem."},{"key":"867_CR151","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11095-015-1791-2","volume":"33","author":"LHE Leithold","year":"2016","unstructured":"Leithold, L. H. E. et al. Pharmacokinetic properties of a novel D-peptide developed to be therapeutically active against toxic \u03b2-amyloid oligomers. Pharm. Res. 33, 328\u2013336 (2016).","journal-title":"Pharm. Res."},{"key":"867_CR152","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.xcrm.2022.100630","volume":"3","author":"B Kass","year":"2022","unstructured":"Kass, B. et al. A\u03b2 oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Rep. Med. 3, 100630 (2022).","journal-title":"Cell Rep. Med."},{"key":"867_CR153","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/cbic.201402430","volume":"15","author":"T Arai","year":"2014","unstructured":"Arai, T. et al. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-\u03b2 oligomers. ChemBioChem. 15, 2577\u20132583 (2014).","journal-title":"ChemBioChem."},{"key":"867_CR154","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","volume":"37","author":"T Yang","year":"2017","unstructured":"Yang, T., Li, S., Xu, H., Walsh, D. M. & Selkoe, D. J. Large soluble oligomers of amyloid \u03b2-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate. J. Neurosci. 37, 152\u2013163 (2017).","journal-title":"J. Neurosci."},{"key":"867_CR155","doi-asserted-by":"publisher","first-page":"102930","DOI":"10.1016\/j.xcrp.2025.102930","volume":"6","author":"AKM Kafi","year":"2025","unstructured":"Kafi, A. K. M. et al. Nucleation dynamics in amyloid-beta dimerization revealed by single molecule fingerprinting. Cell Rep. Phys. Sci. 6, 102930 (2025). This work reports a single-molecule fingerprinting method to investigate the nucleation dynamics of parallel and antiparallel A\u03b21\u201340 dimers, one kind of the very first oligomeric forms along the A\u03b2 misfolding pathway.","journal-title":"Cell Rep. Phys. Sci."},{"key":"867_CR156","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1046\/j.1432-1033.2002.03271.x","volume":"269","author":"O Crescenzi","year":"2002","unstructured":"Crescenzi, O. et al. Solution structure of the Alzheimer amyloid \u03b2-peptide (1\u201342) in an apolar microenvironment: similarity with a virus fusion domain. Eur. J. Biochem. 269, 5642\u20135648 (2002).","journal-title":"Eur. J. Biochem."},{"key":"867_CR157","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/bi00191a006","volume":"33","author":"J Talafous","year":"1994","unstructured":"Talafous, J., Marcinowski, K. J., Klopman, G. & Zagorski, M. G. Solution structure of residues 1\u201328 of the amyloid \u03b2-peptide. Biochem 33, 7788\u20137796 (1994).","journal-title":"Biochem"},{"key":"867_CR158","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbrc.2011.06.133","volume":"411","author":"S Vivekanandan","year":"2011","unstructured":"Vivekanandan, S., Brender, J. R., Lee, S. Y. & Ramamoorthy, A. A partially folded structure of amyloid-beta(1\u201340) in an aqueous environment. Biochem. Biophys. Res. Commun. 411, 312\u2013316 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"867_CR159","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202113845","volume":"61","author":"P Chakraborty","year":"2022","unstructured":"Chakraborty, P. et al. Inhibitor-mediated structural transition in a minimal amyloid model. Angew. Chem. Int. Ed. 61, e202113845 (2022).","journal-title":"Angew. Chem. Int. Ed."},{"key":"867_CR160","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00775-014-1131-8","volume":"19","author":"A Abelein","year":"2014","unstructured":"Abelein, A. et al. The hairpin conformation of the amyloid \u03b2 peptide is an important structural motif along the aggregation pathway. J. Biol. Inorg. Chem. 19, 623\u2013634 (2014).","journal-title":"J. Biol. Inorg. Chem."},{"key":"867_CR161","doi-asserted-by":"publisher","first-page":"16742","DOI":"10.1073\/pnas.262663499","volume":"99","author":"AT Petkova","year":"2002","unstructured":"Petkova, A. T. et al. A structural model for Alzheimer\u2019s-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl Acad. Sci. USA 99, 16742\u201316747 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR162","doi-asserted-by":"publisher","first-page":"17342","DOI":"10.1073\/pnas.0506723102","volume":"102","author":"T L\u00fchrs","year":"2005","unstructured":"L\u00fchrs, T. et al. 3D structure of Alzheimer\u2019s amyloid-(1\u201342) fibrils. Proc. Natl Acad. Sci. USA 102, 17342\u201317347 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR163","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1021\/acs.biochem.3c00526","volume":"63","author":"SM Ruttenberg","year":"2024","unstructured":"Ruttenberg, S. M., Kreutzer, A. G., Truex, N. L. & Nowick, J. S. \u03b2-Hairpin alignment alters oligomer formation in A\u03b2-derived peptides. Biochemistry 63, 212\u2013218 (2024).","journal-title":"Biochemistry"},{"key":"867_CR164","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1560\/5MC0-V3DX-KE0B-YF3J","volume":"45","author":"M Reches","year":"2005","unstructured":"Reches, M. & Gazit, E. Self-assembly of peptide nanotubes and amyloid-like structures by charged-termini-capped diphenylalanine peptide analogues. Isr. J. Chem. 45, 363\u2013371 (2005).","journal-title":"Isr. J. Chem."},{"key":"867_CR165","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1126\/science.1082387","volume":"300","author":"M Reches","year":"2003","unstructured":"Reches, M. & Gazit, E. Casting metal nanowires within discrete self-assembled peptide nanotubes. Science\u00a0300, 625\u2013627 (2003).","journal-title":"Science"},{"key":"867_CR166","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/pro.2164","volume":"21","author":"WM Berhanu","year":"2012","unstructured":"Berhanu, W. M. & Hansmann, U. H. E. Side-chain hydrophobicity and the stability of A\u03b216-22 aggregates. Protein Sci. 21, 1837\u20131848 (2012).","journal-title":"Protein Sci."},{"key":"867_CR167","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ijbiomac.2020.03.064","volume":"156","author":"IM Stankovi\u0107","year":"2020","unstructured":"Stankovi\u0107, I. M., Niu, S., Hall, M. B. & Zari\u0107, S. D. Role of aromatic amino acids in amyloid self-assembly. Int. J. Biol. Macromol. 156, 949\u2013959 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"867_CR168","doi-asserted-by":"publisher","first-page":"15824","DOI":"10.1073\/pnas.0605629103","volume":"103","author":"W Kim","year":"2006","unstructured":"Kim, W. & Hecht, M. H. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer\u2019s A42 peptide. Proc. Natl Acad. Sci. USA 103, 15824\u201315829 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22041859","volume":"22","author":"SG Itoh","year":"2021","unstructured":"Itoh, S. G. & Okumura, H. Promotion and inhibition of amyloid-\u03b2 peptide aggregation: molecular dynamics studies. Int. J. Mol. Sci. 22, 1\u201314 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR170","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature05695","volume":"447","author":"MR Sawaya","year":"2007","unstructured":"Sawaya, M. R. et al. Atomic structures of amyloid cross-\u03b2 spines reveal varied steric zippers. Nature 447, 453\u2013457 (2007).","journal-title":"Nature"},{"key":"867_CR171","doi-asserted-by":"publisher","first-page":"16938","DOI":"10.1073\/pnas.1112600108","volume":"108","author":"J-P Colletier","year":"2011","unstructured":"Colletier, J.-P. et al. Molecular basis for amyloid-\u03b2 polymorphism. Proc. Natl Acad. Sci. USA 108, 16938\u201316943 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR172","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5483\/BMBRep.2024-0044","volume":"57","author":"D Im","year":"2024","unstructured":"Im, D. & Choi, T. S. Distinctive contribution of two additional residues in protein aggregation of A\u03b242 and A\u03b240 isoforms. BMB Rep. 57, 263\u2013272 (2024).","journal-title":"BMB Rep."},{"key":"867_CR173","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1016\/j.bpj.2013.04.056","volume":"104","author":"KA Ball","year":"2013","unstructured":"Ball, K. A., Phillips, A. H., Wemmer, D. E. & Head-Gordon, T. Differences in \u03b2-strand populations of monomeric A\u03b240 and A\u03b242. Biophys. J. 104, 2714\u20132724 (2013).","journal-title":"Biophys. J."},{"key":"867_CR174","doi-asserted-by":"publisher","first-page":"7326","DOI":"10.1021\/acs.chemmater.5c01589","volume":"37","author":"J Kong","year":"2025","unstructured":"Kong, J. et al. Hydrogen bond\u2013driven N-terminal amyloid \u03b2 mimetics attenuate neurotoxic aggregation. Chem. Mater. 37, 7326\u20137336 (2025).","journal-title":"Chem. Mater."},{"key":"867_CR175","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.sbi.2014.12.004","volume":"30","author":"AJ Doig","year":"2015","unstructured":"Doig, A. J. & Derreumaux, P. Inhibition of protein aggregation and amyloid formation by small molecules. Curr. Opin. Struct. Biol. 30, 50\u201356 (2015).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"867_CR176","doi-asserted-by":"publisher","first-page":"11491","DOI":"10.1002\/anie.202002574","volume":"59","author":"JC Lee","year":"2020","unstructured":"Lee, J. C. et al. Discovery of chemicals to either clear or indicate amyloid aggregates by targeting memory-impairing anti-parallel A\u03b2 dimers. Angew. Chem. Int. Ed. 59, 11491\u201311500 (2020). This study develops a surface immobilized antiparallel A\u03b21\u201340 dimer, against which a small library of fluorescent molecules are screened to identify hit compounds, thus demonstrating a novel strategy for evaluating oligomer-specific therapeutics.","journal-title":"Angew. Chem. Int. Ed."},{"key":"867_CR177","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/acschemneuro.2c00449","volume":"14","author":"I Cho","year":"2023","unstructured":"Cho, I. et al. Immobilized amyloid hexamer fragments to map active sites of amyloid-targeting chemicals. ACS Chem. Neurosci. 14, 9\u201318 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR178","doi-asserted-by":"publisher","first-page":"102336","DOI":"10.1016\/j.xcrp.2024.102336","volume":"5","author":"S Pandey","year":"2024","unstructured":"Pandey, S. et al. De novo design of a mechano-pharmaceutical screening platform against formation of individual beta-amyloid oligomers. Cell Rep. Phys. Sci. 5, 102336 (2024). This work develops a single-molecule optical tweezers-based platform to screen compounds that either inhibit or promote formation of a minimal A\u03b2 dimer, demonstrating a proof-of-concept oligomer-specific screening platform for compound evaluation.","journal-title":"Cell Rep. Phys. Sci."},{"key":"867_CR179","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/ph18101457","volume":"18","author":"M Atanasova","year":"2025","unstructured":"Atanasova, M. Small-molecule inhibitors of amyloid beta: insights from molecular dynamics\u2014part B: natural compounds. Pharmaceuticals 18, 1457 (2025).","journal-title":"Pharmaceuticals"},{"key":"867_CR180","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/ph18030306","volume":"18","author":"M Atanasova","year":"2025","unstructured":"Atanasova, M. Small-molecule inhibitors of amyloid beta: insights from molecular dynamics\u2014part A: endogenous compounds and repurposed drugs. Pharmaceuticals 18, 306 (2025).","journal-title":"Pharmaceuticals"},{"key":"867_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/srep33076","volume":"6","author":"Y Mo","year":"2016","unstructured":"Mo, Y., Lei, J., Sun, Y., Zhang, Q. & Wei, G. Conformational ensemble of hIAPP dimer: insight into the molecular mechanism by which a green tea extract inhibits hIAPP aggregation. Sci. Rep. 6, 33076 (2016).","journal-title":"Sci. Rep."},{"key":"867_CR182","doi-asserted-by":"publisher","first-page":"118876","DOI":"10.1016\/j.biopha.2025.118876","volume":"193","author":"S Kim","year":"2025","unstructured":"Kim, S. et al. In silico virtual screening of natural small molecules for dual inhibition of A\u03b2 and tau aggregation in Alzheimer\u2019s disease. Biomed. Pharmacother. 193, 118876 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"867_CR183","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1021\/acschemneuro.4c00097","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Fluorescence-based monitoring of early-stage aggregation of amyloid-\u03b2, amylin peptide, tau, and \u03b1-synuclein proteins. ACS Chem. Neurosci. 15, 3113\u20133123 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR184","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/cbic.201900652","volume":"21","author":"N Tonali","year":"2020","unstructured":"Tonali, N. et al. Real-time BODIPY-binding assay to screen inhibitors of the early oligomerization process of A\u03b21\u201342 peptide. ChemBioChem. 21, 1129\u20131135 (2020).","journal-title":"ChemBioChem."},{"key":"867_CR185","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1021\/acschemneuro.4c00312","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Detecting and tracking \u03b2-amyloid oligomeric forms and dynamics in vitro by a high-sensitivity fluorescent-based assay. ACS Chem. Neurosci. 15, 4383\u20134389 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR186","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1021\/acs.jmedchem.4c00252","volume":"67","author":"B Liu","year":"2024","unstructured":"Liu, B. et al. Iterative design of near-infrared fluorescent probes for early diagnosis of Alzheimer\u2019s disease by targeting A\u03b2 oligomers. J. Med. Chem. 67, 9104\u20139123 (2024).","journal-title":"J. Med. Chem."},{"key":"867_CR187","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1021\/acschemneuro.9b00199","volume":"10","author":"D Lee","year":"2019","unstructured":"Lee, D., Kim, S. M., Kim, H. Y. & Kim, Y. Fluorescence chemicals to detect insoluble and soluble amyloid-\u03b2 aggregates. ACS Chem. Neurosci. 10, 2647\u20132657 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR188","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nchem.2129","volume":"7","author":"LM Young","year":"2015","unstructured":"Young, L. M. et al. Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry. Nat. Chem. 7, 73\u201381 (2015).","journal-title":"Nat. Chem."},{"key":"867_CR189","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1255\/ejms.1359","volume":"21","author":"Y Liu","year":"2015","unstructured":"Liu, Y., Graetz, M., Ho, L. & Pukala, T. L. Ion mobility-mass spectrometry-based screening for inhibition of \u03b1-synuclein aggregation. Eur. J. Mass. Spectrom. 21, 255\u2013264 (2015).","journal-title":"Eur. J. Mass. Spectrom."},{"key":"867_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202411942","volume":"63","author":"S Yoon","year":"2024","unstructured":"Yoon, S. et al. Drug discovery and screening tool development for tauopathies by focusing on pathogenic tau repeat 3 oligomers. Angew. Chem. Int. Ed. 63, e202411942 (2024). This paper presents a strategy to discover therapeutics targeting pathogenic tau oligomers, highlighting translational potential beyond A\u03b2 oligomers.","journal-title":"Angew. Chem. Int. Ed."},{"key":"867_CR191","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin, D. et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat. Commun. 13, 5512 (2022).","journal-title":"Nat. Commun."},{"key":"867_CR192","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13098-023-01082-1","volume":"15","author":"M Alrouji","year":"2023","unstructured":"Alrouji, M. et al. The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer\u2019s diseases. Diabetol. Metab. Syndr. 15, 101 (2023).","journal-title":"Diabetol. Metab. Syndr."},{"key":"867_CR193","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.molcel.2016.07.022","volume":"63","author":"YE Kim","year":"2016","unstructured":"Kim, Y. E. et al. Soluble oligomers of polyQ-expanded Huntingtin target a multiplicity of key cellular factors. Mol. Cell 63, 951\u2013964 (2016).","journal-title":"Mol. Cell"},{"key":"867_CR194","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3390\/ijms20061322","volume":"20","author":"AHS Martinelli","year":"2019","unstructured":"Martinelli, A. H. S., Lopes, F. C., John, E. B. O., Carlini, C. R. & Ligabue-Braun, R. Modulation of disordered proteins with a focus on neurodegenerative diseases and other pathologies. Int. J. Mol. Sci. 20, 1322 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR195","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijbiomac.2022.11.031","volume":"223","author":"AN Khan","year":"2022","unstructured":"Khan, A. N. & Khan, R. H. Protein misfolding and related human diseases: a comprehensive review of toxicity, proteins involved, and current therapeutic strategies. Int. J. Biol. Macromol. 223, 143\u2013160 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"867_CR196","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.abb.2019.01.032","volume":"664","author":"K Sivanesam","year":"2019","unstructured":"Sivanesam, K. & Andersen, N. Pre-structured hydrophobic peptide \u03b2-strands: a universal amyloid trap? Arch. Biochem. Biophys. 664, 51\u201361 (2019).","journal-title":"Arch. Biochem. Biophys."},{"key":"867_CR197","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1007\/s00018-018-2872-2","volume":"75","author":"Z Dhouafli","year":"2018","unstructured":"Dhouafli, Z. et al. Inhibition of protein misfolding and aggregation by natural phenolic compounds. Cell. Mol. Life Sci. 75, 3521\u20133538 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"867_CR198","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow, K. & Zetterberg, H. Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J. Intern. Med. 284, 643\u2013663 (2018).","journal-title":"J. Intern. Med."},{"key":"867_CR199","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson, B. et al. CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 15, 673\u2013684 (2016).","journal-title":"Lancet Neurol."},{"key":"867_CR200","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41586-025-10018-w","volume":"650","author":"H Zetterberg","year":"2026","unstructured":"Zetterberg, H. & Bendlin, B. B. Biofluid biomarkers in Alzheimer\u2019s disease and other neurodegenerative dementias. Nature 650, 49\u201359 (2026).","journal-title":"Nature"},{"key":"867_CR201","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41380-024-02709-z","volume":"30","author":"TR Hunter","year":"2025","unstructured":"Hunter, T. R., Santos, L. E., Tovar-Moll, F. & De Felice, F. G. Alzheimer\u2019s disease biomarkers and their current use in clinical research and practice. Mol. Psychiatry. 30, 272\u2013284 (2025).","journal-title":"Mol. Psychiatry."},{"key":"867_CR202","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1021\/cn500148z","volume":"5","author":"MDC C\u00e1rdenas-Aguayo","year":"2014","unstructured":"C\u00e1rdenas-Aguayo, M. D. C., G\u00f3mez-Virgilio, L., DeRosa, S. & Meraz-R\u00edos, M. A. The role of tau oligomers in the onset of Alzheimer\u2019s disease neuropathology. ACS Chem. Neurosci. 5, 1178\u20131191 (2014).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR203","doi-asserted-by":"publisher","first-page":"116934","DOI":"10.1016\/j.celrep.2026.116934","volume":"45","author":"D B\u00f6ken","year":"2026","unstructured":"B\u00f6ken, D. et al. Nanoscopic tau aggregates are not shared intermediates but disease-specific entities across tauopathies. Cell Rep. 45, 116934 (2026).","journal-title":"Cell Rep."},{"key":"867_CR204","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/pathogens11121559","volume":"11","author":"L Wu","year":"2022","unstructured":"Wu, L., Madhavan, S. S., Tan, C. & Xu, B. Hexameric aggregation nucleation core sequences and diversity of pathogenic tau strains.\u00a0Pathogens\u00a011, 1559 (2022).","journal-title":"Pathogens"},{"key":"867_CR205","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41594-020-0384-x","volume":"27","author":"CPA Doherty","year":"2020","unstructured":"Doherty, C. P. A. et al. A short motif in the N-terminal region of \u03b1-synuclein is critical for both aggregation and function. Nat. Struct. Mol. Biol. 27, 249\u2013259 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"867_CR206","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.3390\/ijms25073845","volume":"25","author":"H Tong","year":"2024","unstructured":"Tong, H. et al. Huntington\u2019s disease: complex pathogenesis and therapeutic strategies. Int. J. Mol. Sci. 25, 3845 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"867_CR207","doi-asserted-by":"publisher","first-page":"2501462","DOI":"10.1002\/advs.202501462","volume":"12","author":"P Mohanty","year":"2025","unstructured":"Mohanty, P., Phan, T. M. & Mittal, J. Transient interdomain interactions modulate the monomeric structural ensemble and self-assembly of Huntingtin exon 1. Adv. Sci. 12, 2501462 (2025).","journal-title":"Adv. Sci."},{"key":"867_CR208","doi-asserted-by":"publisher","first-page":"1419019","DOI":"10.3389\/fchem.2024.1419019","volume":"12","author":"M Alghrably","year":"2024","unstructured":"Alghrably, M. et al. Exploring the central region of amylin and its analogs aggregation: the influence of metal ions and residue substitutions. Front. Chem. 12, 1419019 (2024).","journal-title":"Front. Chem."},{"key":"867_CR209","first-page":"1873","volume":"10","author":"HR Jeong","year":"2015","unstructured":"Jeong, H. R. & An, S. S. A. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus. Clin. Interv. Aging. 10, 1873\u20131879 (2015).","journal-title":"Clin. Interv. Aging."},{"key":"867_CR210","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1073\/pnas.1516725113","volume":"113","author":"EA Proctor","year":"2016","unstructured":"Proctor, E. A. et al. Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 113, 614\u2013619 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"867_CR211","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1021\/acschemneuro.9b00337","volume":"10","author":"V Laos","year":"2019","unstructured":"Laos, V. et al. Characterizing TDP-43307-319 oligomeric assembly: mechanistic and structural implications involved in the etiology of amyotrophic lateral sclerosis. ACS Chem. Neurosci. 10, 4112\u20134123 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"867_CR212","doi-asserted-by":"publisher","first-page":"eaaz6014","DOI":"10.1126\/sciadv.aaz6014","volume":"6","author":"PN Nirmalraj","year":"2020","unstructured":"Nirmalraj, P. N. et al. Complete aggregation pathway of amyloid \u03b2 (1\u201340) and (1\u201342) resolved on an atomically clean interface. Sci. Adv. 6, eaaz6014 (2020).","journal-title":"Sci. Adv."},{"key":"867_CR213","doi-asserted-by":"crossref","unstructured":"Chakraborty, P. & Pradeep, T. in Atomically Precise Metal Nanoclusters (ed. Pradeep, T.) 203\u2013227 (Elsevier, 2022).","DOI":"10.1016\/B978-0-323-90879-5.00022-6"},{"key":"867_CR214","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1039\/C6CS00731G","volume":"46","author":"SJC Lee","year":"2017","unstructured":"Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G. & Lim, M. H. Towards an understanding of amyloid-\u03b2 oligomers: characterization, toxicity mechanisms, and inhibitors. Chem. Soc. Rev. 46, 310\u2013323 (2017).","journal-title":"Chem. Soc. Rev."},{"key":"867_CR215","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong, W. et al. Diffusible, highly bioactive oligomers represent a critical minority of soluble A\u03b2 in Alzheimer\u2019s disease brain. Acta Neuropathol. 136, 19\u201340 (2018).","journal-title":"Acta Neuropathol."},{"key":"867_CR216","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe, D. J. Soluble oligomers of the amyloid \u03b2-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106\u2013113 (2008).","journal-title":"Behav. Brain Res."},{"key":"867_CR217","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar, G. M. et al. Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat. Med. 14, 837\u2013842 (2008). This work demonstrates that soluble A\u03b2 oligomers, including dimers isolated directly from Alzheimer disease brains, disrupt synaptic plasticity and cognitive function, establishing a mechanistic link to neurotoxicity.","journal-title":"Nat. Med."},{"key":"867_CR218","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","volume":"8","author":"JP Cleary","year":"2005","unstructured":"Cleary, J. P. et al. Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79\u201384 (2005). This paper identifies naturally occurring A\u03b2 oligomers including dimers and trimers as selective disruptors of cognitive function in animal models, underlying their role as primary toxic species.","journal-title":"Nat. Neurosci."},{"key":"867_CR219","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/brain\/awv355","volume":"139","author":"A M\u00fcller-Schiffmann","year":"2016","unstructured":"M\u00fcller-Schiffmann, A. et al. Amyloid-\u03b2 dimers in the absence of plaque pathology impair learning and synaptic plasticity. Brain 139, 509\u2013525 (2016).","journal-title":"Brain"},{"key":"867_CR220","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","volume":"572","author":"M Townsend","year":"2006","unstructured":"Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M. & Selkoe, D. J. Effects of secreted oligomers of amyloid \u03b2-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572, 477\u2013492 (2006).","journal-title":"J. Physiol."},{"key":"867_CR221","doi-asserted-by":"publisher","first-page":"642623","DOI":"10.3389\/fcell.2021.642623","volume":"9","author":"M Gonzalez-Garcia","year":"2021","unstructured":"Gonzalez-Garcia, M., Fusco, G. & De Simone, A. Membrane interactions and toxicity by misfolded protein oligomers. Front. Cell Dev. Biol. 9, 642623 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"867_CR222","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol. Psychiatry. 26, 5481\u20135503 (2021).","journal-title":"Mol. Psychiatry."},{"key":"867_CR223","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-025-00479-4","volume":"14","author":"Y Nam","year":"2025","unstructured":"Nam, Y. et al. Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer\u2019s disease: a comprehensive review of the characteristics and therapeutic strategies. Transl. Neurodegener. 14, 15 (2025).","journal-title":"Transl. Neurodegener."},{"key":"867_CR224","doi-asserted-by":"publisher","first-page":"109638","DOI":"10.1016\/j.celrep.2021.109638","volume":"36","author":"HBC Taylor","year":"2021","unstructured":"Taylor, H. B. C., Emptage, N. J. & Jeans, A. F. Long-term depression links amyloid-\u03b2 to the pathological hyperphosphorylation of tau. Cell Rep. 36, 109638 (2021).","journal-title":"Cell Rep."},{"key":"867_CR225","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fncel.2015.00464","volume":"9","author":"MJ Guerrero-Mu\u00f1oz","year":"2015","unstructured":"Guerrero-Mu\u00f1oz, M. J., Gerson, J. & Castillo-Carranza, D. L. Tau oligomers: the toxic player at synapses in Alzheimer\u2019s disease. Front. Cell. Neurosci. 9, 469 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"867_CR226","doi-asserted-by":"publisher","first-page":"11220","DOI":"10.1021\/jp506258g","volume":"118","author":"TD Do","year":"2014","unstructured":"Do, T. D. et al. Interactions between amyloid-\u03b2 and tau fragments promote aberrant aggregates: implications for amyloid toxicity. J. Phys. Chem. B 118, 11220\u201311230 (2014).","journal-title":"J. Phys. Chem. B"},{"key":"867_CR227","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00401-024-02839-2","volume":"149","author":"S Kadamangudi","year":"2025","unstructured":"Kadamangudi, S. et al. Amyloid-\u03b2 oligomers increase the binding and internalization of tau oligomers in human synapses. Acta Neuropathol. 149, 2 (2025).","journal-title":"Acta Neuropathol."},{"key":"867_CR228","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4103\/1673-5374.332127","volume":"17","author":"A Roda","year":"2022","unstructured":"Roda, A., Serra-Mir, G., Montoliu-Gaya, L., Tiessler, L. & Villegas, S. Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease. Neural Regen. Res. 17, 1666\u20131674 (2022).","journal-title":"Neural Regen. Res."},{"key":"867_CR229","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s42003-023-05556-w","volume":"6","author":"FNK Muhammedkutty","year":"2023","unstructured":"Muhammedkutty, F. N. K. et al. A common pathway for detergent-assisted oligomerization of A\u03b242. Commun. Biol. 6, 1184 (2023).","journal-title":"Commun. Biol."},{"key":"867_CR230","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1039\/D0MA00760A","volume":"2","author":"R Rajan","year":"2021","unstructured":"Rajan, R. et al. Review of the current state of protein aggregation inhibition from a materials chemistry perspective: special focus on polymeric materials. Adv. Mater. 2, 1139\u20131176 (2021).","journal-title":"Adv. Mater."}],"container-title":["Nature Reviews Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00867-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:02:23Z","timestamp":1793962943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00867-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":230,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1038\/s41570-026-00867-y","relation":{},"ISSN":["2397-3358"],"issn-type":[{"value":"2397-3358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"17 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}